0.7747
price down icon6.66%   -0.0553
pre-market  Pre-market:  .751   -0.0237   -3.06%
loading
Venus Concept Inc stock is currently priced at $0.7747, with a 24-hour trading volume of 55,337. It has seen a -6.66% decreased in the last 24 hours and a +10.75% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.7693 pivot point. If it approaches the $0.9107 resistance level, significant changes may occur.

Venus Concept Inc Stock (VERO) Financials Data

Venus Concept Inc (VERO) Revenue 2024

VERO reported a revenue (TTM) of $82.51 million for the quarter ending September 30, 2023, a -23.49% decline year-over-year.
loading

Venus Concept Inc (VERO) Net Income 2024

VERO net income (TTM) was -$36.05 million for the quarter ending September 30, 2023, a +5.42% increase year-over-year.
loading

Venus Concept Inc (VERO) Cash Flow 2024

VERO recorded a free cash flow (TTM) of -$15.62 million for the quarter ending September 30, 2023, a +36.48% increase year-over-year.
loading

Venus Concept Inc (VERO) Earnings per Share 2024

VERO earnings per share (TTM) was -$6.94 for the quarter ending September 30, 2023, a +23.31% growth year-over-year.
loading
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
medical_devices PHG
$20.15
price down icon 0.89%
medical_devices STE
$200.24
price up icon 0.62%
$300.14
price down icon 1.63%
medical_devices ZBH
$121.30
price down icon 0.63%
$133.86
price down icon 1.95%
medical_devices EW
$87.24
price down icon 3.12%
Cap:     |  Volume (24h):